China Urology Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report studies the Urology Drugs market. Urology drugs is the branch of drugs that focuses on diseases of the male and female urinary-tract system and the male reproductive organs.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Urology Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Urology Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Urology Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Endo

    • Astellas

    • GP Pharm

    • Tolmar

    By Type:

    • ? (alpha)-blockers

    • 5 ?-reductase inhibitors

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Urology Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Urology Drugs Market Size and Growth Rate of ? (alpha)-blockers from 2016 to 2027

    • 1.3.2 China Urology Drugs Market Size and Growth Rate of 5 ?-reductase inhibitors from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Urology Drugs Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Urology Drugs Market Size and Growth Rate of Clinic from 2016 to 2027

    • 1.4.3 China Urology Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Urology Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Urology Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of ? (alpha)-blockers

    • 3.4.2 Market Size and Growth Rate of 5 ?-reductase inhibitors

    4 Segmentation of Urology Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Urology Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Urology Drugs in Hospital

    • 4.4.2 Market Size and Growth Rate of Urology Drugs in Clinic

    • 4.4.3 Market Size and Growth Rate of Urology Drugs in Others

    5 Market Analysis by Regions

    • 5.1 China Urology Drugs Production Analysis by Regions

    • 5.2 China Urology Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Urology Drugs Landscape Analysis

    • 6.1 North China Urology Drugs Landscape Analysis by Major Types

    • 6.2 North China Urology Drugs Landscape Analysis by Major End-Users

    7 Central China Urology Drugs Landscape Analysis

    • 7.1 Central China Urology Drugs Landscape Analysis by Major Types

    • 7.2 Central China Urology Drugs Landscape Analysis by Major End-Users

    8 South China Urology Drugs Landscape Analysis

    • 8.1 South China Urology Drugs Landscape Analysis by Major Types

    • 8.2 South China Urology Drugs Landscape Analysis by Major End-Users

    9 East China Urology Drugs Landscape Analysis

    • 9.1 East China Urology Drugs Landscape Analysis by Major Types

    • 9.2 East China Urology Drugs Landscape Analysis by Major End-Users

    10 Northeast China Urology Drugs Landscape Analysis

    • 10.1 Northeast China Urology Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Urology Drugs Landscape Analysis by Major End-Users

    11 Southwest China Urology Drugs Landscape Analysis

    • 11.1 Southwest China Urology Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Urology Drugs Landscape Analysis by Major End-Users

    12 Northwest China Urology Drugs Landscape Analysis

    • 12.1 Northwest China Urology Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Urology Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Endo

      • 13.1.1 Endo Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Astellas

      • 13.2.1 Astellas Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 GP Pharm

      • 13.3.1 GP Pharm Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Tolmar

      • 13.4.1 Tolmar Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Urology Drugs Market Size and Growth Rate of ? (alpha)-blockers from 2016 to 2027

    • Figure China Urology Drugs Market Size and Growth Rate of 5 ?-reductase inhibitors from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Urology Drugs Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Urology Drugs Market Size and Growth Rate of Clinic from 2016 to 2027

    • Figure China Urology Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Urology Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Urology Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Urology Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Urology Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Urology Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of ? (alpha)-blockers

    • Figure Market Size and Growth Rate of 5 ?-reductase inhibitors

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Urology Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Urology Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Others

    • Table China Urology Drugs Production by Regions

    • Table China Urology Drugs Production Share by Regions

    • Figure China Urology Drugs Production Share by Regions in 2016

    • Figure China Urology Drugs Production Share by Regions in 2021

    • Figure China Urology Drugs Production Share by Regions in 2027

    • Table China Urology Drugs Consumption by Regions

    • Table China Urology Drugs Consumption Share by Regions

    • Figure China Urology Drugs Consumption Share by Regions in 2016

    • Figure China Urology Drugs Consumption Share by Regions in 2021

    • Figure China Urology Drugs Consumption Share by Regions in 2027

    • Table North China Urology Drugs Consumption by Types from 2016 to 2027

    • Table North China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Urology Drugs Consumption Share by Types in 2016

    • Figure North China Urology Drugs Consumption Share by Types in 2021

    • Figure North China Urology Drugs Consumption Share by Types in 2027

    • Table North China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Urology Drugs Consumption Share by End-Users in 2016

    • Figure North China Urology Drugs Consumption Share by End-Users in 2021

    • Figure North China Urology Drugs Consumption Share by End-Users in 2027

    • Table Central China Urology Drugs Consumption by Types from 2016 to 2027

    • Table Central China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Urology Drugs Consumption Share by Types in 2016

    • Figure Central China Urology Drugs Consumption Share by Types in 2021

    • Figure Central China Urology Drugs Consumption Share by Types in 2027

    • Table Central China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Urology Drugs Consumption Share by End-Users in 2016

    • Figure Central China Urology Drugs Consumption Share by End-Users in 2021

    • Figure Central China Urology Drugs Consumption Share by End-Users in 2027

    • Table South China Urology Drugs Consumption by Types from 2016 to 2027

    • Table South China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Urology Drugs Consumption Share by Types in 2016

    • Figure South China Urology Drugs Consumption Share by Types in 2021

    • Figure South China Urology Drugs Consumption Share by Types in 2027

    • Table South China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Urology Drugs Consumption Share by End-Users in 2016

    • Figure South China Urology Drugs Consumption Share by End-Users in 2021

    • Figure South China Urology Drugs Consumption Share by End-Users in 2027

    • Table East China Urology Drugs Consumption by Types from 2016 to 2027

    • Table East China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Urology Drugs Consumption Share by Types in 2016

    • Figure East China Urology Drugs Consumption Share by Types in 2021

    • Figure East China Urology Drugs Consumption Share by Types in 2027

    • Table East China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Urology Drugs Consumption Share by End-Users in 2016

    • Figure East China Urology Drugs Consumption Share by End-Users in 2021

    • Figure East China Urology Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Urology Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Urology Drugs Consumption Share by Types in 2016

    • Figure Northeast China Urology Drugs Consumption Share by Types in 2021

    • Figure Northeast China Urology Drugs Consumption Share by Types in 2027

    • Table Northeast China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Urology Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Urology Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Urology Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Urology Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Urology Drugs Consumption Share by Types in 2016

    • Figure Southwest China Urology Drugs Consumption Share by Types in 2021

    • Figure Southwest China Urology Drugs Consumption Share by Types in 2027

    • Table Southwest China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Urology Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Urology Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Urology Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Urology Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Urology Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Urology Drugs Consumption Share by Types in 2016

    • Figure Northwest China Urology Drugs Consumption Share by Types in 2021

    • Figure Northwest China Urology Drugs Consumption Share by Types in 2027

    • Table Northwest China Urology Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Urology Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Urology Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Urology Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Urology Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Endo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo

    • Figure Sales and Growth Rate Analysis of Endo

    • Figure Revenue and Market Share Analysis of Endo

    • Table Product and Service Introduction of Endo

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of GP Pharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GP Pharm

    • Figure Sales and Growth Rate Analysis of GP Pharm

    • Figure Revenue and Market Share Analysis of GP Pharm

    • Table Product and Service Introduction of GP Pharm

    • Table Company Profile and Development Status of Tolmar

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tolmar

    • Figure Sales and Growth Rate Analysis of Tolmar

    • Figure Revenue and Market Share Analysis of Tolmar

    • Table Product and Service Introduction of Tolmar


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.